Nephrology

Nephrology Seminar CME / CPD 

Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:   Emergency Physicians, Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, Physician Assistants (PA-C's)

Series 3 (NP3) Topics Include:  Kidney Cancer and Stones, Topics in Nephrology, Kidney Diseases, Adrenal Health, Renal Radiology, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
NP3
Full Course Price:
$580
Short Course:
NP3A, NP3B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Kidney Cancer and Stones

Summarize American Urological Association guidelines for management of patients with clinical T1 renal masses; Choose appropriate therapy for patients with stage 1 RCC; Plan a course of antibiotic treatment in patients undergoing percutaneous nephrolithotomy; Select appropriate first-line systemic therapy for patients with metastatic RCC; Explain the limitations of systemic therapies currently used in the management of metastatic RCC.

Topics in Nephrology

Counsel patients about the risk for renal complications associated with the use of nonsteroidal anti-inflammatory drugs; Choose the appropriate dose of trimethoprim-sulfamethoxazole based on creatinine clearance; Manage renal complications associated with the use of loop diuretics; Implement strategies to slow progression of CKD; Select the appropriate patients for referral to a nephrologist.

Notes on Nephropathy

Diagnose acute kidney injury according to the most recently published criteria; Apply new guidelines for the prevention and management of acute kidney injury; Recognize the contributions of genetics and epigenetics to the development of obesity; Identify mechanisms by which obesity influences renal physiology and function; Explain the role of fatty kidney in the development of chronic kidney disease.

Kidney Diseases

Recognize risk factors for the development of renal calculi; Evaluate patients with renal calculi; Provide patients with effective options for treatment and prevention of renal calculi; Select patients most likely to benefit from percutaneous nephrolithotomy; Weigh the advantages and disadvantages of the various positioning options for patients undergoing percutaneous nephrolithotomy.

Stone Management

Perform appropriate preoperative evaluation for patients undergoing percutaneous nephrolithotomy (PNCL); Identify adverse events most commonly encountered during PCNL; Manage bleeding complications related to PCNL; Evaluate innovative approaches in the treatment of kidney stones; Incorporate advances in robotic surgery into clinical management of stone disease.

Clinical Pearls in Nephrology

Recognize the indications and contraindications for using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers; Determine the indications for medical management or surgical revascularization for renal artery stenosis; Identify and avoid nephrotoxic medications when necessary; Explain the pathogenesis of DKA; Recommend optimal treatment of euglycemic DKA secondary to use of a sodium-glucose cotransporter 2 inhibitor.

Highlights for the Northeastern Genitouriniary Oncology Symposium, Part 2: What's New in Bladder and Kidney Cancers

Outline an institutional plan for responding to a drug shortage; Summarize ways to use less bacillus Calmette-Gu?rin during a shortage; Recognize emerging renal cancer entities; Explain the importance of histology type in hereditary renal cancer; Screen patients suspected of having increased risk for hereditary renal cancer.

Kidney and Adrenal Health

Identify factors that affect stone-free rates for patients undergoing extracorporeal shockwave lithotripsy; Improve performance of extracorporeal shockwave lithotripsy; Provide appropriate ureteroscopic treatment for patients with renal stones; Select patients most likely to benefit from ureteroscopic resection of transitional cell carcinoma; Implement techniques for optimal results in ureteroscopic resection of transitional cell carcinoma.

Chronic Kidney Disease/Urinary Tract Infections

Identify stages of CKD based on cause, glomerular filtration rate (GFR), and albuminuria; Discuss blood pressure targets and safe potassium levels in patients with CKD; Compare creatinine testing to cystatin C testing for estimating GFR; Recognize patients with asymptomatic bacteriuria in whom treatment is indicated; Review risks and benefits of antibiotic treatment of acute uncomplicated cystitis.

Renal Radiology

Plan the radiologic evaluation of vascular anomalies in children; Recognize life-threatening problems associated with vascular anomalies in children; Utilize cryoablation for the treatment of renal cell carcinoma (RCC); Compare oncologic outcomes of ablation techniques with those of nephrectomy for RCC; Contrast ablation techniques for the treatment of RCC.

Kidney Cancer and Stones

Summarize American Urological Association guidelines for management of patients with clinical T1 renal masses; Choose appropriate therapy for patients with stage 1 RCC; Plan a course of antibiotic treatment in patients undergoing percutaneous nephrolithotomy; Select appropriate first-line systemic therapy for patients with metastatic RCC; Explain the limitations of systemic therapies currently used in the management of metastatic RCC.

Notes on Nephropathy

Diagnose acute kidney injury according to the most recently published criteria; Apply new guidelines for the prevention and management of acute kidney injury; Recognize the contributions of genetics and epigenetics to the development of obesity; Identify mechanisms by which obesity influences renal physiology and function; Explain the role of fatty kidney in the development of chronic kidney disease.

Stone Management

Perform appropriate preoperative evaluation for patients undergoing percutaneous nephrolithotomy (PNCL); Identify adverse events most commonly encountered during PCNL; Manage bleeding complications related to PCNL; Evaluate innovative approaches in the treatment of kidney stones; Incorporate advances in robotic surgery into clinical management of stone disease.

Highlights for the Northeastern Genitouriniary Oncology Symposium, Part 2: What's New in Bladder and Kidney Cancers

Outline an institutional plan for responding to a drug shortage; Summarize ways to use less bacillus Calmette-Gu?rin during a shortage; Recognize emerging renal cancer entities; Explain the importance of histology type in hereditary renal cancer; Screen patients suspected of having increased risk for hereditary renal cancer.

Chronic Kidney Disease/Urinary Tract Infections

Identify stages of CKD based on cause, glomerular filtration rate (GFR), and albuminuria; Discuss blood pressure targets and safe potassium levels in patients with CKD; Compare creatinine testing to cystatin C testing for estimating GFR; Recognize patients with asymptomatic bacteriuria in whom treatment is indicated; Review risks and benefits of antibiotic treatment of acute uncomplicated cystitis.

Topics in Nephrology

Counsel patients about the risk for renal complications associated with the use of nonsteroidal anti-inflammatory drugs; Choose the appropriate dose of trimethoprim-sulfamethoxazole based on creatinine clearance; Manage renal complications associated with the use of loop diuretics; Implement strategies to slow progression of CKD; Select the appropriate patients for referral to a nephrologist.

Kidney Diseases

Recognize risk factors for the development of renal calculi; Evaluate patients with renal calculi; Provide patients with effective options for treatment and prevention of renal calculi; Select patients most likely to benefit from percutaneous nephrolithotomy; Weigh the advantages and disadvantages of the various positioning options for patients undergoing percutaneous nephrolithotomy.

Clinical Pearls in Nephrology

Recognize the indications and contraindications for using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers; Determine the indications for medical management or surgical revascularization for renal artery stenosis; Identify and avoid nephrotoxic medications when necessary; Explain the pathogenesis of DKA; Recommend optimal treatment of euglycemic DKA secondary to use of a sodium-glucose cotransporter 2 inhibitor.

Kidney and Adrenal Health

Identify factors that affect stone-free rates for patients undergoing extracorporeal shockwave lithotripsy; Improve performance of extracorporeal shockwave lithotripsy; Provide appropriate ureteroscopic treatment for patients with renal stones; Select patients most likely to benefit from ureteroscopic resection of transitional cell carcinoma; Implement techniques for optimal results in ureteroscopic resection of transitional cell carcinoma.

Renal Radiology

Plan the radiologic evaluation of vascular anomalies in children; Recognize life-threatening problems associated with vascular anomalies in children; Utilize cryoablation for the treatment of renal cell carcinoma (RCC); Compare oncologic outcomes of ablation techniques with those of nephrectomy for RCC; Contrast ablation techniques for the treatment of RCC.

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include:  PediatricsFamily PracticeInternal MedicineObesity and Nutrition.

If you have taken the current Nephrology CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

For over 30 years, ASI has provided Continuing Medical Education, CME & CEU and Continuing Professional Development Education (CPD) for physicians and allied professionals in Nephrology plus over 40 other specialties and subspecialties.  Lectures are recorded annually at the top seminars and conferences to provide the most current medical education to our clients.